1064 related articles for article (PubMed ID: 28648400)
1. Oesophageal cancer.
Lagergren J; Smyth E; Cunningham D; Lagergren P
Lancet; 2017 Nov; 390(10110):2383-2396. PubMed ID: 28648400
[TBL] [Abstract][Full Text] [Related]
2. Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma.
Li SH; Rau KM; Lu HI; Wang YM; Tien WY; Liang JL; Lin WC
Eur J Cardiothorac Surg; 2012 Dec; 42(6):958-64. PubMed ID: 22466694
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer].
Fuchs HF; Hölscher AH
Zentralbl Chir; 2014 Feb; 139(1):32-6. PubMed ID: 24585195
[TBL] [Abstract][Full Text] [Related]
4. Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study.
Markar SR; Gronnier C; Pasquer A; Duhamel A; Beal H; Théreaux J; Gagnière J; Lebreton G; Brigand C; Meunier B; Collet D; Mariette C;
Eur J Cancer; 2016 Mar; 56():59-68. PubMed ID: 26808298
[TBL] [Abstract][Full Text] [Related]
5. [Management of esophageal squamous cell carcinoma and adenocarcinoma: surgical, endoscopic, and radiotherapeutic options].
González Tallón AI; Rodríguez Gandía MÁ; Fernández Lizarbe E
Med Clin (Barc); 2012 Dec; 139(13):588-92. PubMed ID: 22841469
[No Abstract] [Full Text] [Related]
6. Anatomical distribution of residual cancer in patients with oesophageal squamous cell carcinoma who achieved clinically complete response after neoadjuvant chemoradiotherapy.
Chao YK; Chuang WY; Yeh CJ; Chang HK; Tseng CK
Eur J Cardiothorac Surg; 2018 Jan; 53(1):201-208. PubMed ID: 28977486
[TBL] [Abstract][Full Text] [Related]
7. Management of Patients With Adenocarcinoma or Squamous Cancer of the Esophagus.
Ilson DH; van Hillegersberg R
Gastroenterology; 2018 Jan; 154(2):437-451. PubMed ID: 29037469
[TBL] [Abstract][Full Text] [Related]
8. Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage I esophageal squamous cell carcinoma.
Yamamoto S; Ishihara R; Motoori M; Kawaguchi Y; Uedo N; Takeuchi Y; Higashino K; Yano M; Nakamura S; Iishi H
Am J Gastroenterol; 2011 Jun; 106(6):1048-54. PubMed ID: 21343920
[TBL] [Abstract][Full Text] [Related]
9. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
[TBL] [Abstract][Full Text] [Related]
10. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
Burt BM; Groth SS; Sada YH; Farjah F; Cornwell L; Sugarbaker DJ; Massarweh NN
Ann Surg; 2017 Aug; 266(2):297-304. PubMed ID: 27501170
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of age in the radical treatment of oesophageal cancer with surgery or chemoradiotherapy: a prospective observational cohort study.
Davies L; Lewis WG; Arnold DT; Escofet X; Blackshaw G; Gwynne S; Evans M; Roberts SA; Appadurai I; Crosby TD
Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):578-85. PubMed ID: 20591633
[TBL] [Abstract][Full Text] [Related]
12. Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry.
Klevebro F; Lindblad M; Johansson J; Lundell L; Nilsson M
Br J Surg; 2016 Dec; 103(13):1864-1873. PubMed ID: 27689845
[TBL] [Abstract][Full Text] [Related]
13. [Non-metastatic oesophageal cancer: diagnosis and treatment].
Voeten DM; den Bakker CM; Goedegebuure RSA; Heineman DJ; Daams F; van der Peet DL
Ned Tijdschr Geneeskd; 2019 Sep; 163():. PubMed ID: 31556490
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal analysis of cytokine expression during neoadjuvant chemoradiotherapy and subsequent surgery in esophageal cancer patients.
Bosch DJ; Wang D; Nijsten MW; Mul VE; Hospers GA; Burgerhof JG; Struys MM; Plukker JT
Am J Surg; 2016 Jul; 212(1):89-95. PubMed ID: 27036621
[TBL] [Abstract][Full Text] [Related]
15. Sex Disparities After Induction Chemoradiotherapy and Esophagogastrectomy for Esophageal Cancer.
Rowse PG; Jaroszewski DE; Thomas M; Harold K; Harmsen WS; Shen KR
Ann Thorac Surg; 2017 Oct; 104(4):1147-1152. PubMed ID: 28842111
[TBL] [Abstract][Full Text] [Related]
16. Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer?
Van De Voorde L; Janssen L; Larue R; Houben R; Buijsen J; Sosef M; Vanneste B; Schraepen MC; Berbée M; Lambin P
Eur J Surg Oncol; 2015 Oct; 41(10):1333-9. PubMed ID: 26091848
[TBL] [Abstract][Full Text] [Related]
17. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
[TBL] [Abstract][Full Text] [Related]
18. Cancer of the esophagus and gastric cardia: recent advances.
Tytgat GN; Bartelink H; Bernards R; Giaccone G; van Lanschot JJ; Offerhaus GJ; Peters GJ
Dis Esophagus; 2004; 17(1):10-26. PubMed ID: 15209736
[TBL] [Abstract][Full Text] [Related]
19. [Timing of esophagectomy in multimodal therapy of esophageal cancer: Impact of time interval between neoadjuvant therapy and surgery on outcome and response].
Müller AK; Lenschow C; Palmes D; Senninger N; Hummel R; Lindner K
Chirurg; 2015 Sep; 86(9):874-80. PubMed ID: 25662991
[TBL] [Abstract][Full Text] [Related]
20. Treatment strategies for esophageal cancer.
Nieman DR; Peters JH
Gastroenterol Clin North Am; 2013 Mar; 42(1):187-97. PubMed ID: 23452638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
